Keyphrases
Epigenetic Therapy
100%
DNA Methyltransferase Inhibitor
64%
Ovarian Cancer
42%
Histone Deacetylase Inhibitor (HDACi)
36%
Microenvironment
27%
Tumor Protein p53 (TP53)
25%
Tumor Microenvironment
24%
Immune Checkpoint Therapy
21%
DNA Methylation (DNAm)
21%
TP53 mutant
21%
Myeloid-derived Suppressor Cells
21%
Immune Signaling
21%
CD8+ T Cells
21%
5-azacytidine
20%
Cancer Therapy
20%
Clinical Trials
20%
PARP Inhibitor (PARPi)
19%
Viral Mimicry
19%
Tumor Burden
17%
CCL5
17%
Repetitive Elements
17%
Age Impact
17%
Potentiator
17%
DNMT Inhibition
17%
Pharmacologic
17%
Production Team
17%
Nuclear Factor of Activated T Cells
17%
Innate Immune Signaling
17%
Homologous Recombination Deficiency
17%
Enhancer of Zeste Homolog 2 Inhibitors
17%
COVID-19 Review
17%
Activator protein-1 (AP-1)
17%
STING1
17%
Immune Checkpoint Blockade
17%
Pre-metastatic
17%
Immunosuppression
17%
Pre-metastatic Niche
17%
CD8+ T Cell Infiltration
17%
Non-small Cell Lung Cancer (NSCLC)
17%
Type I Interferon Signaling
17%
Histone Acetylation
17%
BRCAness Phenotype
17%
Immuno-oncology
17%
Histone Methylation
17%
Acute Myeloid Leukemia
17%
Metastasis
17%
Space Radiation
17%
Radiation Damage
17%
Spaceflight
17%
MicroRNA
17%
Medicine and Dentistry
Epigenetic Therapy
85%
DNA Methyltransferase Inhibitor
64%
Azacitidine
55%
Malignant Neoplasm
47%
Lung Cancer
41%
PARP Inhibitor
36%
Severe Acute Respiratory Syndrome Coronavirus 2
35%
COVID-19
35%
Infection
35%
Non Small Cell Lung Cancer
35%
Low Drug Dose
33%
Neoplasm
31%
Ovarian Cancer
27%
Interferon
24%
Homologous Recombination
23%
Myeloid-Derived Suppressor Cell
21%
Entinostat
20%
In Vitro
17%
Sensitization
17%
Cytotoxic Chemotherapy
17%
Acute Myeloid Leukemia
17%
Immune Evasion
17%
Breast Cancer
17%
Ionizing Radiation
17%
Immunosuppressive Treatment
17%
Interferon Type I
17%
Metastatic Carcinoma
17%
Immunoregulation
17%
Upregulation
16%
Antigen Presentation
16%
Histone Deacetylase Inhibitor
15%
Xenograft
14%
T Cell
13%
Primary Tumor
11%
Clinical Trial
11%
Gene Expression
11%
Disease
10%
Irinotecan
10%
Non-Small Cell Lung Cancer
10%
Triple Negative Breast Cancer
10%
Macrophage
9%
DNA Repair
9%
Immunotherapy
9%
The Cancer Genome Atlas
9%
Tumor Cell
9%
Solid Malignant Neoplasm
7%
Krukenberg Tumor
7%
Chemotherapy
7%
Natural Killer Cell
7%
Immunocompetent Cell
7%
Biochemistry, Genetics and Molecular Biology
DNA Methyltransferase
88%
Epigenetic Therapy
59%
DNA Methylation
42%
Immune Checkpoints
40%
Histone Deacetylase
33%
Epigenetics
32%
Poly ADP Ribose Polymerase
31%
Low Drug Dose
29%
Colon
26%
Cancer Cell
23%
Homologous Recombination
21%
T Cell
21%
Synapsin I
21%
Poly ADP Ribose Polymerase
21%
Histone
21%
Gene Expression
20%
Transcription
19%
Demethylating Agent
18%
Transcription Factor NFAT
17%
Azacitidine
17%
Immune Evasion
17%
Antigen Presentation
17%
Transcription Factor EZH2
17%
Upregulation
17%
UHRF1
17%
Histone Demethylation
17%
Immunoregulation
17%
Deacetylation
17%
Phase II Trials
17%
Cosmic Radiation
17%
Methylation
17%
Interferon
16%
interferon
16%
Antagomir
13%
DNA Repair
11%
Lysine
10%
Cell Death
10%
Double-Stranded RNA
10%
Clinical Trial
9%
P53
8%
Gene Promoter
8%
Enhancer Region
8%
Corepressor
8%
Wild Type
8%
Cell Mutant
8%
Demethylase
8%
Histone Methylation
8%
Enzyme
8%
Histone Acetylation
8%
MicroRNA
8%
